Lexi Pharma Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Lexi Pharma General Information
Description
Developer of pharmaceutical drugs in Canada. The company provides AP-002, a new chemical entity small molecule with an active US FDA IND, that focuses on bone resorption and anti-tumor activity.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- Canada
Corporate Office
- Canada
Lexi Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lexi Pharma Patents
Lexi Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018146551-A2 | Compositions of gallium (iii) complexes for oral administration | Inactive | 10-Feb-2017 | ||
| WO-2018146551-A3 | Compositions of gallium (iii) complexes for oral administration | Inactive | 10-Feb-2017 |
Lexi Pharma FAQs
-
Where is Lexi Pharma headquartered?
Lexi Pharma is headquartered in Canada.
-
What industry is Lexi Pharma in?
Lexi Pharma’s primary industry is Pharmaceuticals.
-
Is Lexi Pharma a private or public company?
Lexi Pharma is a Private company.
-
What is Lexi Pharma’s current revenue?
The current revenue for Lexi Pharma is .
-
When was Lexi Pharma acquired?
Lexi Pharma was acquired on 30-Apr-2018.
-
Who acquired Lexi Pharma?
Lexi Pharma was acquired by Altum Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process